Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Riekkinen

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
BMJ (Clinical Research Ed.)|August 21, 1993
Remission of seizures in untreated epilepsyT Keränen, P J Riekkinen
Acta Neurologica Scandinavica. Supplementum|January 11, 1992
EEG in diagnostics and follow-up of Alzheimer's diseaseH Soininen, P J Riekkinen
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapyK Alhainen, P J Riekkinen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1983
[The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease]K Reinikainen, P J Riekkinen
Acta Neurologica Scandinavica|January 1, 1970
Peptidase activity of purified myelinP J Riekkinen, J Clausen
Metabolism: Clinical and Experimental|September 1, 1990
Somatostatin and epilepsyP J Riekkinen, A Pitkänen
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studiesJ Sirviö, P J Riekkinen
Acta Psychiatrica Scandinavica|June 1, 1991
Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholismH Koponen, P J Riekkinen
Advances in Experimental Medicine and Biology|January 1, 1978
Peripheral nerves as target tissue of the immune response in EAN. A neurochemical and morphological studyG K Molnár, P J Riekkinen
Trends in Neurosciences|June 1, 1996
Apolipoprotein E, memory and Alzheimer's diseaseH S Soininen, P J Riekkinen
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
BMJ (Clinical Research Ed.)|August 21, 1993
Remission of seizures in untreated epilepsyT Keränen, P J Riekkinen
Acta Neurologica Scandinavica. Supplementum|January 11, 1992
EEG in diagnostics and follow-up of Alzheimer's diseaseH Soininen, P J Riekkinen
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapyK Alhainen, P J Riekkinen
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1983
[The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease]K Reinikainen, P J Riekkinen
Acta Neurologica Scandinavica|January 1, 1970
Peptidase activity of purified myelinP J Riekkinen, J Clausen
Metabolism: Clinical and Experimental|September 1, 1990
Somatostatin and epilepsyP J Riekkinen, A Pitkänen
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studiesJ Sirviö, P J Riekkinen
Acta Psychiatrica Scandinavica|June 1, 1991
Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholismH Koponen, P J Riekkinen
Advances in Experimental Medicine and Biology|January 1, 1978
Peripheral nerves as target tissue of the immune response in EAN. A neurochemical and morphological studyG K Molnár, P J Riekkinen
Trends in Neurosciences|June 1, 1996
Apolipoprotein E, memory and Alzheimer's diseaseH S Soininen, P J Riekkinen
Pageof 24